Ebunat 0.5mg Injection: Effective Medical Solution

Ebunat 0.5mg Injection

Description:

• Ebunat 0.5mg Injection is a chemotherapy drug containing the active substance eribulin.
• It belongs to the class of antineoplastic agents and is used in adults for advanced breast cancer or liposarcoma when other treatments have stopped working.

Uses:

• Advanced breast cancer
• Liposarcoma

Therapeutic Effects:

• Ebunat 0.5mg Injection stops the growth and spread of cancer cells by targeting the growth phase of microtubules.
• It prevents cell division without interfering with the shrinking phase.
• Tubulin, a protein essential for cell division, clumps together, disrupting cell division and leading to cell death through apoptosis.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
• Certain medications may interact with Ebunat 0.5mg Injection and reduce effectiveness or cause undesirable side effects.

Safety Advice:

• Pregnancy: Ebunat 0.5mg Injection is unsafe for pregnant women as it may cause fetal harm.
• Breastfeeding: Ebunat 0.5mg Injection is not recommended while breastfeeding.
• Lungs: Ebunat 0.5mg Injection can cause side effects like blood clots in the lungs and inflammation of the lungs.
• Liver: Ebunat 0.5mg Injection can affect the liver's normal functioning.
• Alcohol: Patients taking Ebunat 0.5mg Injection should avoid or limit their alcohol intake.
• Driving: Ebunat 0.5mg Injection causes tiredness and dizziness, which may impair your ability to drive, cycle, or operate machinery.

Side Effects:

• Serious: Sepsis (severe infection), severe allergic reaction, serious skin conditions (Stevens-Johnson syndrome).
• Common: Decrease in the number of white blood cells or red blood cells, tiredness or weakness, nausea, vomiting, constipation, diarrhea, numbness, tingling or prickling sensations, fever, loss of appetite, weight loss, difficulty breathing, cough, pain in the joints, muscles, and back, headache, hair loss.

Word of Advice:

• Your doctor will monitor your liver function via blood tests and assess your heart function before and during treatment.
• Women who could become pregnant should use reliable birth control while taking Ebunat 0.5mg Injection and for at least three months after stopping it.
• Consult your doctor for guidance on alternative contraception methods.
• Talk to your oncologist if you need dental treatment.
• Always tell your dentist you are having cancer treatment.
• This treatment can affect fertility in men and women.

FAQs:

1. What is the most important information I should know while taking Ebunat 0.5mg Injection?

   • Ebunat 0.5mg Injection can cause serious adverse effects such as low white blood cell count and numbness, tingling, and pain in the hands and feet. Inform your physician immediately if you face any of these symptoms.

2. Does Ebunat 0.5mg Injection cause infertility?

   • Yes, Ebunat 0.5mg Injection causes infertility in men and women. It is necessary to use effective birth control methods during the treatment and for three weeks (females) and 14 weeks (males) after the final dose of the injection.

3. Is hair loss caused by Ebunat 0.5mg Injection reversible?

   • Hair loss is a common side effect of Ebunat 0.5mg Injection. It is reversible, but it depends totally on the severity of the hair loss and varies from person to person. Consult your doctor if you have severe hair loss.

4. Do I have to follow any special dietary requirements while taking Ebunat 0.5mg Injection?

   • It depends upon the severity of the disease condition. You can have a normal diet until your physician tells you to follow any special food or diet chart. Check with your doctor if you have any nutrition concerns.

5. What should I do if I miss taking Ebunat 0.5mg Injection?

   • It is important to get the injection at the right time. If you missed your appointment, contact your healthcare provider and schedule your dosing immediately. Keep follow-ups on your next schedule.

Fact Box:

• Molecule name: Eribulin
• Therapeutic class: Anticancer
• Pharmacological class: Monoclonal antibody-drug conjugate
• Indications: Advanced breast cancer, liposarcoma
• Dosage form: Injections
• Habit forming: No

Tags: medical-injection, ebunat-injection, pharmaceuticals, 0.5mg-injection, drug-injection